Clinical Trial Update: Investigation of Pharmacokinetics and Safety of HRS-7535 in Subjects With Hepatic Impairment and Normal Hepatic Function [Phase 1]

View source ↗

Summary

A Phase 1 study evaluated the pharmacokinetics and safety of HRS-7535 in subjects with hepatic impairment and normal hepatic function in the context of diabetes…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• HRS-7535 (HRS-7535)

Snippet

Sponsor: Shandong Suncadia Medicine Co., Ltd. | Conditions: Diabetes Mellitus | Phase 1 | Status: COMPLETED